Comparative Randomized, Single Dose, Three-Arm, Parallel Open-Label Study to Characterize the Pharmacokinetics of 7.5 Mg Olanzapine Intranasal Spray and 7.5 Mg Olanzapine Intramuscular Injection After Administration to Healthy Male Adults Under Fasting Conditions
Latest Information Update: 30 Sep 2024
At a glance
- Drugs Olanzapine (Primary) ; Olanzapine
- Indications Agitation
- Focus Pharmacokinetics
- Sponsors Neurelis
- 30 Sep 2024 New trial record